Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Balthaser Kevin. Officer active across 1 company, notably Aclaris Therapeutics, Inc.. In total, 13 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €70k. History available since 1 September 2023. The latest transaction was disclosed on 1 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.